Invenia Group reposted this
𝐈𝐭’𝐬 𝐛𝐞𝐞𝐧 𝐚 𝐰𝐞𝐞𝐤 𝐬𝐢𝐧𝐜𝐞 𝐀𝐀𝐂𝐑 𝐤𝐢𝐜𝐤𝐞𝐝 𝐨𝐟𝐟 𝐢𝐧 𝐒𝐚𝐧 𝐃𝐢𝐞𝐠𝐨. We had a great time (despite the jet lag), always a highlight to get face-to-face with so many clients and candidates, and to attend some brilliant events (the Multiomics Mixer didn’t disappoint 🍻). As always, #AACR26 delivered, from new platform launches to partnerships, and a clear shift in where the industry is heading. 𝗔 𝗳𝗲𝘄 𝘁𝗵𝗲𝗺𝗲𝘀 𝘁𝗵𝗮𝘁 𝘀𝘁𝗼𝗼𝗱 𝗼𝘂𝘁 𝘁𝗼 𝗺𝗲: → Spatial biology continuing its move towards clinical adoption → AI becoming embedded across workflows, not just layered on top → Growing focus on multi-omic integration and real-world utility → WGS and MRD gaining real traction in clinical conversations There was a lot going on, so I’ve pulled together a few highlights in the slides below 👇 I’m sure I’ve missed plenty, would love to hear: 𝗪𝗵𝗮𝘁 𝘀𝘁𝗼𝗼𝗱 𝗼𝘂𝘁 𝘁𝗼 𝘆𝗼𝘂? Any companies or announcements we should be watching? 👀 #AACR2026 #SpatialBiology #Multiomics #AIinBiology #Genomics #LifeSciences Andrew Maddison, James Chippindale 10x Genomics, Revolune, RareCyte, Inc., Precede Biosciences, MESO SCALE DIAGNOSTICS, LLC., Vizgen, Elucidate Bio, Tempus AI, Predicta Biosciences, Strand AI (YC W26), Personalis, Inc., PreludeDx, Quanterix, Oxford Nanopore Technologies, Genomize, Geneyx Genomex Ltd., Golden Helix, Inc., Agilent Technologies, Mithrl, Elephas, Panome Bio, Audubon Bioscience, Nomic Bio, Broad Clinical Labs, Inocras Inc., Institute for Precision Medicine, Bioptimus, Takara Bio USA, Inc., Spatomics, Stellaromics Inc., Parhelia Biosciences, Epigenica, Mithrl, Aspect Analytics, LatchBio, Mindpeak, PredxBio, Pluto Bio, Glint Lab, Sapient, Teiko, PictorLabs, Indica Labs, Visiopharm, Evident Microscopy, Molecular Instruments, Guardant Health, Exact Sciences, ClearNote Health